Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 1.000 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.672 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.645 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.645 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.626 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.618 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.607 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.589 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.580 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.576 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.576 | |
| 2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.575 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.569 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.567 | |
| 2itx | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.567 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.564 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.555 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.554 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.554 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.554 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.550 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.549 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.542 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.537 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.537 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.536 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.535 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.530 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.529 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.528 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.526 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.526 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.525 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.523 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.521 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.520 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.519 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.519 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.516 | |
| 2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.516 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.515 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.515 | |
| 1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.513 | |
| 2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.513 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.513 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.511 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.511 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.510 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.509 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.509 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.509 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.509 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.508 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.508 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.508 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.508 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.508 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.507 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.507 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.507 | |
| 3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.507 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.507 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.504 | |
| 2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.503 | |
| 3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.503 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.503 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.502 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.501 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.501 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.499 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.499 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.498 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.498 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.498 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.494 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.494 | |
| 2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.493 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.493 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.493 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.492 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.492 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.492 | |
| 2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
| 3acj | KSS | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.491 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 4i0t | 1B6 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.490 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.489 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.489 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.489 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.487 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.487 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.487 | |
| 4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.487 | |
| 2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.486 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.486 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.486 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.485 | |
| 3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.484 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.484 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.484 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.483 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.483 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.483 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.482 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.481 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.481 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.481 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.481 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.481 | |
| 1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
| 2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.479 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.478 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.478 | |
| 4kb8 | 1QO | Casein kinase I isoform delta | 2.7.11.1 | 0.478 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.477 | |
| 2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.477 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.476 | |
| 2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.476 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.476 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.475 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.475 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.474 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.474 | |
| 1agw | SU2 | Fibroblast growth factor receptor 1 | / | 0.473 | |
| 1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.473 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.473 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.473 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.473 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.473 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.473 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.472 | |
| 4u7w | NDP | MxaA | / | 0.472 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.471 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.470 | |
| 4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.470 | |
| 2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.469 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.469 | |
| 1snu | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.468 | |
| 2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.468 | |
| 2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.468 | |
| 4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.468 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.468 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.468 | |
| 5c8w | PCG | cGMP-dependent protein kinase 2 | 2.7.11.12 | 0.468 | |
| 1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.467 | |
| 2p5u | NAD | UDP-glucose 4-epimerase | / | 0.467 | |
| 2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
| 3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
| 4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.467 | |
| 1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.466 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 2v9j | ATP | 5'-AMP-activated protein kinase subunit gamma-1 | / | 0.466 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.466 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.466 | |
| 4app | N53 | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.466 | |
| 4fyn | 0VE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.466 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.466 | |
| 5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.466 | |
| 1bws | NDP | GDP-L-fucose synthase | / | 0.465 | |
| 1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.465 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.465 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.465 | |
| 4gfg | 0XF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.465 | |
| 4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.465 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.465 | |
| 1psa | 0ZL | Pepsin A | 3.4.23.1 | 0.464 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.464 | |
| 4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.464 | |
| 4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.464 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.464 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.463 | |
| 3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.463 | |
| 3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.463 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 4wbo | ANW | Rhodopsin kinase | / | 0.463 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.463 | |
| 5dgz | L20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.463 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.462 | |
| 1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.462 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.462 | |
| 1e8x | ATP | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.461 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.461 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 4tv3 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.461 | |
| 1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.460 | |
| 3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
| 4fz6 | 0VG | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.460 | |
| 4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.460 | |
| 4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.460 | |
| 2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.459 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.459 | |
| 4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.459 | |
| 2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.458 | |
| 2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.458 | |
| 2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.458 | |
| 3gbu | ATP | Uncharacterized sugar kinase PH1459 | 2.7.1 | 0.458 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.458 | |
| 3tuc | FPW | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.458 | |
| 4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.458 | |
| 1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.457 | |
| 3ag9 | A02 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.457 | |
| 3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.457 | |
| 3pjc | PJC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.457 | |
| 3s1d | ZIR | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.457 | |
| 4hyi | 1AO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
| 1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.456 | |
| 2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
| 3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.456 | |
| 3zrk | ZRK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.456 | |
| 4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.456 | |
| 4otp | ADP | Serine/threonine-protein kinase RIO1 | 2.7.11.1 | 0.456 | |
| 4wh3 | ATP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.456 | |
| 2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.455 | |
| 3btj | DEQ | HTH-type transcriptional regulator QacR | / | 0.455 | |
| 3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.455 | |
| 3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
| 4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.455 | |
| 4xwt | U5P | Ribonuclease J | / | 0.455 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
| 2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 2vtt | LZD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 3hz5 | Z64 | Heat shock protein HSP 90-alpha | / | 0.454 | |
| 3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.454 | |
| 3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 3u9e | COA | Lmo1369 protein | / | 0.454 | |
| 4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.454 | |
| 4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
| 2znq | 401 | Peroxisome proliferator-activated receptor delta | / | 0.453 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.453 | |
| 4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.453 | |
| 4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
| 4h95 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.453 | |
| 5iub | CLR | Adenosine receptor A2a | / | 0.453 | |
| 1e8z | STU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 1y0s | 331 | Peroxisome proliferator-activated receptor delta | / | 0.452 | |
| 2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 2has | C3O | Vitamin D3 receptor | / | 0.452 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.452 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.452 | |
| 3el7 | PD3 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 4ckj | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.452 | |
| 4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
| 4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.452 | |
| 5a3b | APR | SIR2 family protein | / | 0.452 | |
| 1bsv | NDP | GDP-L-fucose synthase | / | 0.451 | |
| 1h66 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.451 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 2y8q | ADP | 5'-AMP-activated protein kinase subunit gamma-1 | / | 0.451 | |
| 3cr0 | 809 | Wee1-like protein kinase | 2.7.10.2 | 0.451 | |
| 3el4 | ROC | Gag-Pol polyprotein | 3.4.23.16 | 0.451 | |
| 3l9l | L9L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.451 | |
| 3vt7 | VDX | Vitamin D3 receptor | / | 0.451 | |
| 4acd | GR9 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.451 | |
| 1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.450 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.450 | |
| 3dds | 26B | Glycogen phosphorylase, liver form | 2.4.1.1 | 0.450 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.450 | |
| 4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.450 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.450 | |
| 4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
| 4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.450 | |
| 2izt | 23D | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.449 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.449 | |
| 2y1o | T26 | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.449 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.449 | |
| 2yer | TQ1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 3a78 | 3EV | Vitamin D3 receptor | / | 0.449 | |
| 4dja | FAD | (6-4) photolyase | / | 0.449 | |
| 4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.449 | |
| 1p0h | ACO | Mycothiol acetyltransferase | 2.3.1.189 | 0.448 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 2a5u | QYT | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.448 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.448 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.448 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.448 | |
| 4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
| 4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.448 | |
| 4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
| 4ix6 | ADP | Uncharacterized protein | / | 0.448 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.448 | |
| 1nzd | UPG | DNA beta-glucosyltransferase | / | 0.447 | |
| 2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.447 | |
| 2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.447 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
| 2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.447 | |
| 3aid | ARQ | Gag-Pol polyprotein | 3.4.23.16 | 0.447 | |
| 3iod | A6D | Pantothenate synthetase | 6.3.2.1 | 0.447 | |
| 4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.447 | |
| 4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.447 | |
| 4fhj | 0TZ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
| 1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.446 | |
| 1klk | PMD | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
| 1tqm | ANP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.446 | |
| 1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.446 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 3ml9 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
| 3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.446 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
| 4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.445 | |
| 2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
| 2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.445 | |
| 2yex | YEX | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 4ftq | 4HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 4kky | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
| 4mgi | CMP | Rap guanine nucleotide exchange factor 4 | / | 0.445 | |
| 1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 1hfq | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 2chw | 039 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 3gwf | FAD | Cyclohexanone monooxygenase | / | 0.444 | |
| 3oqf | S51 | Renin | 3.4.23.15 | 0.444 | |
| 3r7e | X88 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 4fgg | 0U5 | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.444 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.444 | |
| 4xhg | ADP | Uncharacterized protein | / | 0.444 | |
| 1fxs | NAP | GDP-L-fucose synthase | / | 0.443 | |
| 1t7j | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 1u3c | FAD | Cryptochrome-1 | / | 0.443 | |
| 1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 1zao | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.443 | |
| 2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 2hma | SAM | tRNA-specific 2-thiouridylase MnmA | / | 0.443 | |
| 2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.443 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.443 | |
| 2y8l | ADP | 5'-AMP-activated protein kinase subunit gamma-1 | / | 0.443 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.443 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.443 | |
| 4aw5 | 30K | Ephrin type-B receptor 4 | 2.7.10.1 | 0.443 | |
| 4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.443 | |
| 4dk5 | 0KO | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.443 | |
| 4kf1 | HT5 | Aryldialkylphosphatase | 3.1.8.1 | 0.443 | |
| 5a3c | NAD | SIR2 family protein | / | 0.443 | |
| 1uu9 | BI3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
| 2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 3bgz | VX3 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
| 3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.442 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.442 | |
| 3gob | HXX | DdmC | / | 0.442 | |
| 3i8a | N22 | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
| 3tvu | B37 | Acetyl-CoA carboxylase | / | 0.442 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.442 | |
| 4c59 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.442 | |
| 4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
| 4fz7 | 0VH | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.442 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.442 | |
| 4oth | DRN | Serine/threonine-protein kinase N1 | / | 0.442 | |
| 5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.442 | |
| 1h5r | THM | Glucose-1-phosphate thymidylyltransferase 1 | / | 0.441 | |
| 1phe | PIY | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
| 2nq8 | ZID | Enoyl-ACP reductase | / | 0.441 | |
| 3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
| 3t4n | ADP | 5'-AMP-activated protein kinase subunit gamma | / | 0.441 | |
| 3vbq | 0F5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
| 3vw6 | IM6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.441 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.440 | |
| 1hdc | CBO | 3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase | 1.1.1.53 | 0.440 | |
| 1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.440 | |
| 2b7z | MK1 | Gag-Pol polyprotein | / | 0.440 | |
| 2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2ham | C33 | Vitamin D3 receptor | / | 0.440 | |
| 2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.440 | |
| 2pmo | HMD | Protein kinase 7 | / | 0.440 | |
| 2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.440 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.440 | |
| 2wip | P49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 3dv3 | MEK | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.440 | |
| 3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3krw | BA1 | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.440 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
| 3s79 | ASD | Aromatase | 1.14.14.14 | 0.440 | |
| 3wb2 | YGP | Uncharacterized protein MJ0488 | / | 0.440 | |
| 3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.440 |